For the first time in history, a drug has been developed to restrict the growth of Alzheimer’s disease. Presently, trials for the drug are in progression in Australia.

According to researchers, the drug will surely not allow the birth of brain protein that is responsible for maturity of Alzheimer disease.

As defined by Samantha Donovan, when Alzheimer begins developing in human brain, the main symptom to notice is that the affected person starts forgetting some basic but particular things. Other than this, there are no other signs to identify dementia. The person lives a moderately normal life.

In Australia and 14 more countries, the category of people on which the trials of the latest drug are being practiced consists of individuals suffering from some or other kinds of memory associated problems.

Michael Woodward, head of Aged Care at Austin Health in Melbourne, also associated Alzheimer with memory problems and he also indicated that this kind of defect can lay a bad impact over the person’s day-to-day life.